# Statistical Approaches to Establishing Bioequivalence - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/statistical-approaches-to-establishing-bioequivalence/3391de1a-8097-49d5-83f8-195b2013a5e2

> FDA guidance document: Statistical Approaches to Establishing Bioequivalence. Issue date: February 01, 2001. Get complete insights and analysis.

---

## Details

- Title: Statistical Approaches to Establishing Bioequivalence
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-02-01
- Last Changed: 2020-04-29
- Docket Number: <a href="https://www.regulations.gov/docket/01D-0027">01D-0027</a>

## Related Documents

- [Changes to an Approved NDA or ANDA: Questions and Answers:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/changes-to-an-approved-nda-or-anda-questions-and-answers-guidance-for-industry/35e76fcd-a993-489c-8472-73c4bbb60d94)
- [Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/alternate-source-of-the-active-pharmaceutical-ingredient-in-pending-andas-guidance-for-industry/8a3da1bc-1ebb-48aa-a3ea-7662562c4370)
- [Integration of Dose-Counting Mechanisms into MDI Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/integration-of-dose-counting-mechanisms-into-mdi-drug-products/b523d7a1-3c0a-423e-ac27-f899492e96ff)